{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:16:33Z","timestamp":1778166993201,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clml.2025.06.010","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T11:05:10Z","timestamp":1750763110000},"page":"e834-e843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identifying Risk Factors and Outcome for CNS Involvement in AML"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8815-5290","authenticated-orcid":false,"given":"Jack T.","family":"Seki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina S.","family":"Daher-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4613-3680","authenticated-orcid":false,"given":"Eshetu G.","family":"Atenafu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jad","family":"Sibai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniket","family":"Bankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayler","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4354-0731","authenticated-orcid":false,"given":"Steven","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Yee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Minden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Maze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Schuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Schimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-8583","authenticated-orcid":false,"given":"Hassan","family":"Sibai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2025.06.010_bib0001","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.26253","article-title":"Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease","volume":"118","author":"Shihadeh","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2025.06.010_bib0002","first-page":"577","article-title":"The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement","volume":"82","author":"Castagnola","year":"1997","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2025.06.010_bib0003","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0002-9343(87)90756-X","article-title":"Central nervous system involvement in acute nonlymphocytic leukemia. A prospective study of adults in remission","volume":"83","author":"Peterson","year":"1987","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.clml.2025.06.010_bib0004","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3109\/10428194.2014.953148","article-title":"Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia","volume":"56","author":"Rozovski","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2025.06.010_bib0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12885-015-1376-9","article-title":"Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement criptin adults","volume":"15","author":"Chieh-Lung","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2025.06.010_bib0006","first-page":"97","article-title":"Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia","volume":"9","author":"Alakel","year":"2017","journal-title":"Ca Manage Res"},{"issue":"1","key":"10.1016\/j.clml.2025.06.010_bib0007","doi-asserted-by":"crossref","first-page":"68","DOI":"10.21037\/atm-20-3140","article-title":"A narrative review of central nervous system involvement in acute leukemias","volume":"9","author":"Deak","year":"2021","journal-title":"Ann Transl Med"},{"issue":"4","key":"10.1016\/j.clml.2025.06.010_bib0008","first-page":"209","article-title":"CNS involvement in leukaemia. An autopsy study of 100 consecutive patients","volume":"91","author":"Bojsen-M\u00f8ller","year":"1983","journal-title":"Acta Pathol Microbiol Immunol Scand A"},{"key":"10.1016\/j.clml.2025.06.010_bib0009","doi-asserted-by":"crossref","first-page":"e3253","DOI":"10.1002\/hon.3253","article-title":"Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute Myeloid leukemia","author":"Virijevic","year":"2024","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2025.06.010_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.seminhematol.2018.02.006","article-title":"Involvement of central nervous system in adult patients with acute myeloid leukemia: incidence and impact on outcome","volume":"55","author":"Del principe","year":"2018","journal-title":"Sem Hematol"},{"key":"10.1016\/j.clml.2025.06.010_bib0011","first-page":"257","article-title":"Primary and secondary Central nervous system involvement in acute","volume":"7","author":"Patkowska","year":"2019","journal-title":"Myeloid Leukemia J Leuk"},{"key":"10.1016\/j.clml.2025.06.010_bib0012","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2025.06.010_bib0013","doi-asserted-by":"crossref","unstructured":"Johnston DL Alonzo T.A., Gerbing R.B., Lange B.J. and Woods W.G. The presence of Central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a children\u2019s oncology group study pediatr blood cancer. 55(3) (2010) 414-420. doi:10.1002\/pbc.22511.","DOI":"10.1002\/pbc.22511"},{"key":"10.1016\/j.clml.2025.06.010_bib0014","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.hemonc.2020.11.004","article-title":"Prognostic factors for clinical outcomes of patients with central nervous system leukemia","volume":"14","author":"Bharucha","year":"2021","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.clml.2025.06.010_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MPH.0000000000001034","article-title":"Acute myeloid leukemia with Central nervous system involvement in children: experience from the French protocol analysis ELAM02","volume":"40","author":"Felix","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"issue":"no. 3","key":"10.1016\/j.clml.2025.06.010_bib0016","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1988.6.3.495","article-title":"High peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemia","volume":"6","author":"Cassileth","year":"1988","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1016\/j.clml.2025.06.010_bib0017","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1200\/JCO.1995.13.7.1800","volume":"13","author":"Byrd","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2025.06.010_bib0018","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.leukres.2004.01.006","article-title":"Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome","volume":"28","author":"Chang","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2025.06.010_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2022.106882","article-title":"Central nervous system involvement in adult acute myeloid leukemia patients","volume":"118","author":"Tatarian","year":"2022","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2025.06.010_bib0020","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/ajh.24799","article-title":"Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia","volume":"92","author":"Jabbour","year":"2017","journal-title":"Am J Hematol"},{"issue":"22","key":"10.1016\/j.clml.2025.06.010_bib0021","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1182\/bloodadvances.2021004999","article-title":"CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials","volume":"5","author":"Ganzel","year":"2021","journal-title":"Blood Adv First Edition"},{"issue":"7","key":"10.1016\/j.clml.2025.06.010_bib0022","first-page":"2346","volume":"109","author":"Blum","year":"2024","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.clml.2025.06.010_bib0023","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.clml.2025.06.010_bib0024","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations","volume":"15","author":"Eckardt","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clml.2025.06.010_bib0025","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.leukres.2008.04.011","article-title":"Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and\/or at first relapse: results from the GETLALA group","volume":"32","author":"Reman","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2025.06.010_bib0026","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5045\/br.2017.52.3.159","article-title":"Advances in the treatment of newly diagnosed primary central nervous system lymphomas","volume":"52","author":"Qian","year":"2017","journal-title":"Blood Res"},{"key":"10.1016\/j.clml.2025.06.010_bib0027","doi-asserted-by":"crossref","unstructured":"Anders Kallner, Laboratory Statistics (Second Edition), Elsevier, Stockholm, Sweden 2018, Pages 1-140, ISBN 9780128143483.","DOI":"10.1016\/B978-0-12-814348-3.00001-0"},{"key":"10.1016\/j.clml.2025.06.010_bib0028","unstructured":"Alberta Health Services. CLINICAL PRACTICE GUIDELINE LYHE-006 version 6. Acute Myeloid Leukemia. http:\/\/www.albertahealthservices.ca\/2019 (Accessed: February 3, 2022)."},{"key":"10.1016\/j.clml.2025.06.010_bib0029","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s11864-022-01032-5","article-title":"Fang PQ, Central nervous system prophylaxis and treatment in acute leukemias","volume":"23","author":"Wu","year":"2022","journal-title":"Curr Treat Opt Oncol."},{"key":"10.1016\/j.clml.2025.06.010_bib0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1200\/JCO.1990.8.1.75","article-title":"Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia","volume":"8","author":"Kalwinsky","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2025.06.010_bib0031","doi-asserted-by":"crossref","first-page":"9172","DOI":"10.1200\/JCO.2005.02.7482","article-title":"Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia","volume":"23","author":"Johnston","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2025.06.010_bib0032","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s12185-016-2063-6","article-title":"Clinical outcome and efficacy of current antileukemic therapy for leptomeningeal involvement in acute myeloid leukemia","volume":"104","author":"Kwon","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2025.06.010_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107452","article-title":"Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement","volume":"137","author":"Goulart","year":"2024","journal-title":"Leuk Res"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025002150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025002150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:18:33Z","timestamp":1762600713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025002150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2152265025002150"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.06.010","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying Risk Factors and Outcome for CNS Involvement in AML","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}